nbi 27914 has been researched along with pregna-4,17-diene-3,16-dione, (17z)-isomer in 3 studies
| Studies (nbi 27914) | Trials (nbi 27914) | Recent Studies (post-2010) (nbi 27914) | Studies (pregna-4,17-diene-3,16-dione, (17z)-isomer) | Trials (pregna-4,17-diene-3,16-dione, (17z)-isomer) | Recent Studies (post-2010) (pregna-4,17-diene-3,16-dione, (17z)-isomer) |
|---|---|---|---|---|---|
| 76 | 0 | 29 | 15 | 0 | 8 |
| Protein | Taxonomy | nbi 27914 (IC50) | pregna-4,17-diene-3,16-dione, (17z)-isomer (IC50) |
|---|---|---|---|
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | 0.0024 | |
| Glucocorticoid receptor | Homo sapiens (human) | 6.06 | |
| Progesterone receptor | Homo sapiens (human) | 0.74 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 1.88 | |
| Androgen receptor | Homo sapiens (human) | 0.66 | |
| Bile acid receptor | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Chen, T; Forman, BM; Lin, W; Yu, DD | 1 |
3 other study(ies) available for nbi 27914 and pregna-4,17-diene-3,16-dione, (17z)-isomer
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.
Topics: Biological Assay; Drug Discovery; Fluoresceins; Fluorescence Resonance Energy Transfer; Fluorescent Dyes; Gene Expression Regulation; Isoxazoles; Molecular Structure; Protein Binding; Receptors, Cytoplasmic and Nuclear | 2013 |